Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance

This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.

Detalles Bibliográficos
Autores principales: Cham, Stephanie, Landrum, Mary Beth, Keating, Nancy L., Armstrong, Joanne, Wright, Alexi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753497/
https://www.ncbi.nlm.nih.gov/pubmed/35015069
http://dx.doi.org/10.1001/jamanetworkopen.2021.42703
_version_ 1784632109137133568
author Cham, Stephanie
Landrum, Mary Beth
Keating, Nancy L.
Armstrong, Joanne
Wright, Alexi A.
author_facet Cham, Stephanie
Landrum, Mary Beth
Keating, Nancy L.
Armstrong, Joanne
Wright, Alexi A.
author_sort Cham, Stephanie
collection PubMed
description This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates.
format Online
Article
Text
id pubmed-8753497
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-87534972022-01-25 Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance Cham, Stephanie Landrum, Mary Beth Keating, Nancy L. Armstrong, Joanne Wright, Alexi A. JAMA Netw Open Research Letter This cross-sectional study evaluates changes in the rate of germline BRCA testing among patients with ovarian cancer between 2008 and 2018 and analyzes factors associated with testing rates. American Medical Association 2022-01-11 /pmc/articles/PMC8753497/ /pubmed/35015069 http://dx.doi.org/10.1001/jamanetworkopen.2021.42703 Text en Copyright 2022 Cham S et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Cham, Stephanie
Landrum, Mary Beth
Keating, Nancy L.
Armstrong, Joanne
Wright, Alexi A.
Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title_full Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title_fullStr Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title_full_unstemmed Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title_short Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
title_sort use of germline brca testing in patients with ovarian cancer and commercial insurance
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753497/
https://www.ncbi.nlm.nih.gov/pubmed/35015069
http://dx.doi.org/10.1001/jamanetworkopen.2021.42703
work_keys_str_mv AT chamstephanie useofgermlinebrcatestinginpatientswithovariancancerandcommercialinsurance
AT landrummarybeth useofgermlinebrcatestinginpatientswithovariancancerandcommercialinsurance
AT keatingnancyl useofgermlinebrcatestinginpatientswithovariancancerandcommercialinsurance
AT armstrongjoanne useofgermlinebrcatestinginpatientswithovariancancerandcommercialinsurance
AT wrightalexia useofgermlinebrcatestinginpatientswithovariancancerandcommercialinsurance

Ejemplares similares